RxDoctor Payments Data

Corinne McCullion, PA

Physician Assistant · Gainesville, GANPI 1598320756

Payments from drug & device makers

$1,649in general payments, 2019–2025

Across 40 payments — averaging $41.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Galderma Laboratories, L.p.$151
  • Janssen Scientific Affairs, LLC$136
  • Arcutis Biotherapeutics, Inc.$128
  • Boston Scientific$128
  • Organon$127
  • Sanofi$125
  • plus $854 from 15 others

What the payments were for

  • Food & beverage$1,649100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,649 in reported general payments places this provider in the 75th percentile of 3,581 physician assistant providers in Georgia.

See all physician assistant providers in Georgia

Medicare billing

Part B allowed, 2024
$2,634
Medicare patients
22
Services billed
38

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Triamcinolone Acetonide138$3,697
Tacrolimus38$3,401
Calcipotriene28$2,929
VecticalCalcitriol15$2,294
Clobetasol Propionate70$1,450
Ketoconazole71$1,378
Fluorouracil27$1,068
Desonide43$871
Fluocinonide46$744
Metronidazole28$437
Doxycycline Monohydrate18$280
Ciclopirox13$237
Clindamycin Phosphate11$225
Mupirocin20$195
Finasteride13$187

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Galderma Laboratories, L.p.Vectical$151$2,29415 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 3,581 physician assistant providers in Georgia.

Other physician assistant in Gainesville

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →